Pluri Inc. (PLUR)
Pluri, Inc. is a clinical stage company, which engages in cell therapy development. It develops placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory, and hematologic conditions. The firm focuses on the research, development, and manufacturing of cell-based products and technologies. Its products include Clinical Pipeline, PLX-Immune, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.
Address
MATAM ADVANCED TECHNOLOGY PARK
HAIFA, L3 3508409
Founded
2001
Number of Employees
134
Website
http://www.pluri-biotech.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)